How can social listening help your health care business?
Common objectives in HCP social listening.
How are HCPs making prescribing decisions in my therapeutic area? What are their questions and challenges?
What topics, questions, and content are highest priority to HCPs in my key specialties?
Who are the most digitally-influential HCPs in my therapeutic area? Are my DOL assumptions correct?
How are HCPs reacting to clinical trial results, FDA approvals, and FDA labeling requirements?
How are HCPs reacting to data presented at medical Congresses? What are the most influential HCPs saying?
Common objectives in patient & caregiver social listening.
What new insights can I gain into the patient journey? How do emotions and triggers define the journey?
What digital and social content is most impacting patients’ decisions?
How do patients perceive available therapies? Where do they get information on therapeutic options?
What are patients’ most critical education and information needs?
What role do friends, family, and caregivers play in patients’ diagnosis and treatment decisions?
-
Oncology
Solid tumor and hematologic malignancies
-
Gastroenterology
IBD, Crohn’s, Ulcerative Colitis, and other chronic GI conditions
-
Dermatology
Conditions such as Hidradenitis suppurativa, Atopic Dermatitis, and Chronic Idiopathic Urticaria
-
Psychiatry
Major depressive disorder, bipolar disorder, and schizophrenia
-
Rare Diseases
Rare conditions which are difficult to recruit for in traditional market research
-
Medical Aesthetics
Fillers, toxins, and other medical aesthetic procedures
DOWNLOAD EXAMPLE REPORT
Gut Check: How HCPs and consumers think about the microbiome.
ANALYZES 80,000 consumer and 14,000 physician online conversations about the gut microbiome.
COMPARES Physicians’ and consumers’ divergent priorities and expectations of the gut microbiome.
IDENTIFIES opportunities for pharmaceutical companies, investors, and agencies.